Skip to main content
. 2018 Jan 5;50(1):e418. doi: 10.1038/emm.2017.159

Figure 2.

Figure 2

The validation of the gene expression signature of FOXM1 in independent cohorts. (a) Overall survival and (b) recurrence-free survival in HCC patients, stratified by the co-expressed gene set of FOXM1, were estimated in the Fudan cohort (n=242). (c) Overall survival and (d) recurrence-free survival were also estimated in the TCGA cohort (n=331). FH, FOXM1-high; FL, FOXM1-low.